BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24690483)

  • 21. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
    Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
    World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel APC gene mutations associated with protein alteration in diffuse type gastric cancer.
    Ghatak S; Chakraborty P; Sarkar SR; Chowdhury B; Bhaumik A; Kumar NS
    BMC Med Genet; 2017 Jun; 18(1):61. PubMed ID: 28576136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.
    Jacobs G; Hellmig S; Huse K; Titz A; Franke A; Kwiatkowski R; Ott S; Kosmahl M; Fischbach W; Lucius R; Klapper W; Fölsch UR; Hampe J; Schreiber S; Rosenstiel P
    Haematologica; 2011 Jul; 96(7):987-95. PubMed ID: 21459793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline CDH1 deletions in hereditary diffuse gastric cancer families.
    Oliveira C; Senz J; Kaurah P; Pinheiro H; Sanges R; Haegert A; Corso G; Schouten J; Fitzgerald R; Vogelsang H; Keller G; Dwerryhouse S; Grimmer D; Chin SF; Yang HK; Jackson CE; Seruca R; Roviello F; Stupka E; Caldas C; Huntsman D
    Hum Mol Genet; 2009 May; 18(9):1545-55. PubMed ID: 19168852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
    Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
    Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.
    Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M
    Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients.
    Kim S; Chung JW; Jeong TD; Park YS; Lee JH; Ahn JY; Kim DH; Choi KD; Lee W; Song HJ; Lee GH; Chun S; Jung HY; Min WK; Kim JH
    Fam Cancer; 2013 Sep; 12(3):503-7. PubMed ID: 23264079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
    Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of E-Cadherin and
    García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
    Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
    Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
    Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
    Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
    PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.